Literature DB >> 31812258

Identification of inhibitors of the immunosuppressive enzyme IL4I1.

Marc Presset1, Diana Djordjevic2, Aurélie Dupont2, Erwan Le Gall1, Valérie Molinier-Frenkel3, Flavia Castellano4.   

Abstract

Entities:  

Keywords:  Cancer therapy; Immunosuppressive enzymes; Inhibitors; Phenylalanine derivatives

Mesh：

Substances：

Year:  2019        PMID： 31812258     DOI： 10.1016/j.bioorg.2019.103463

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN： 0045-2068            Impact factor:   5.275


× No keyword cloud information.
  3 in total

1.  What role for AHR activation in IL4I1-mediated immunosuppression ?

Authors:  Flavia Castellano; Armelle Prevost-Blondel; José L Cohen; Valérie Molinier-Frenkel
Journal:  Oncoimmunology       Date:  2021-05-12       Impact factor: 8.110

2.  Single-cell analysis revealed that IL4I1 promoted ovarian cancer progression.

Authors:  Hongyu Zhao; Yu Teng; Wende Hao; Jie Li; Zhefeng Li; Qi Chen; Chenghong Yin; Wentao Yue
Journal:  J Transl Med       Date:  2021-10-30       Impact factor: 5.531

3.  IL-4i1 Regulation of Immune Protection During Mycobacterium tuberculosis Infection.

Authors:  Lerato Hlaka; Mumin Ozturk; Julius E Chia; Shelby-Sara Jones; Shandre Pillay; Sibongiseni K L Poswayo; Thabo Mpotje; Justin K Nono; Simphiwe R N Simelane; Suraj P Parihar; Sugata Roy; Harukazu Suzuki; Frank Brombacher; Reto Guler
Journal:  J Infect Dis       Date:  2021-12-15       Impact factor: 5.226
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.